Target intelligence / Profile preview

BAIAP2 divergent transcript (BAIAP2-DT)

Target
BAIAP2-DT
Molecular classification
Long non-coding RNA (lncRNA), Antisense non-coding RNA, Divergent transcript
01

Overview

BAIAP2 divergent transcript (BAIAP2-DT) is a long non-coding RNA gene transcribed in the antisense direction relative to the BAIAP2 protein-coding gene. Like many divergent lncRNAs, BAIAP2-DT originates from a promoter region near a protein-coding gene and is part of a gene pair that is often co-regulated. Experimental evidence confirms that BAIAP2-DT (lnc-BAIAP2) is a bona fide lncRNA transcript. It functions primarily as a *cis* regulator of its neighboring gene BAIAP2, influencing the expression of pro-inflammatory cytokines such as IL-6 and IL-1α in the context of bacterial infection, particularly in macrophage responses to Group B Streptococcus. The broader biological significance of BAIAP2-DT and other similar divergent lncRNAs includes regulation of gene expression, intergenic signaling, and evolutionary conservation of regulatory elements. However, BAIAP2-DT is not a classical druggable target, and its function is currently understood to be regulatory, not enzymatic or receptor-like.

Other names
lnc-BAIAP2BAIAP2-AS1BAIAP2 antisense RNA 1 (head to head)BAIAP2 antisense RNA 1 (non-protein coding)BAIAP2 divergent transcript
02

Biological functions

Gene regulation (in cis, influencing expression of neighboring BAIAP2)Regulation of inflammatory cytokine production (e.g., IL-6, IL-1α in response to infection)Implicated in transcriptional control and cellular response to stress and infection
03

Disease associations

Inflammation (regulation of cytokine response in infection with Group B Streptococcus)Other (long non-coding RNAs, in general, are implicated in diverse roles such as cancer, development, and gene regulation, but disease roles for BAIAP2-DT beyond inflammation are not specifically documented in the current literature)

Beyond the preview

Go deeper on BAIAP2 divergent transcript (BAIAP2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BAIAP2 divergent transcript (BAIAP2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call